Exponent (EXPO) shares are back in focus after the company reported double digit revenue growth for Q2 2026, raised full year revenue and EBITDA guidance, and expanded its stock repurchase program.

Despite Q2 2026 results and guidance putting Exponent back in the spotlight, the stock’s recent moves tell a mixed story, with a 1 month share price return of 11.53% and a year to date share price decline of 4.70%, while the 5 year total shareholder return has fallen 38.18%. This suggests that near term momentum contrasts with weaker longer term compounding.

If you are looking beyond Exponent for other ideas in the current market, this could be a useful time to scan 18 top founder-led companies

After a sharp 30 day rebound but a weaker 5 year record, Exponent now sits at an interesting crossroads. Investors may consider whether to act after this move or instead wait for a clearer entry based on valuation.

Most Popular Narrative: 18.1% Undervalued

Based on the most followed narrative, Exponent’s fair value of $81.67 sits well above the last close at $66.85, which puts a spotlight on the assumptions behind that gap.

Ongoing expansion into high-growth, innovation-driven domains, including artificial intelligence safety, distributed energy systems, and advanced medical technologies, broadens Exponent's addressable market and client base, setting up an accelerating revenue trajectory as these industries scale.

Strengthening headcount growth, propelled by effective recruiting and a development-focused culture, enables Exponent to capture more project volume and maintain its reputation-driven pricing power, with positive implications for both top-line growth and sustained high net margins.

Want to see why this narrative thinks Exponent can support a richer future earnings base and a premium profit profile? The key drivers sit in the revenue path, margin assumptions and how much investors might be willing to pay for those profits.

Result: Fair Value of $81.67 (UNDERVALUED)

However, the Exponent narrative also faces pressure from softer utilization and workforce trends, as well as slower growth in key regulatory focused segments.

Another View: Multiples Point To An Expensive Exponent

The analyst narrative and DCF style work suggest Exponent trades below a fair value estimate, yet the market multiple tells a different story. At a P/E of 29x versus 23.2x for the US Professional Services industry and a fair ratio of 16.3x, the stock screens expensive. That gap raises a simple question for investors: Is the risk that the share price moves toward the modelled fair ratio, or that earnings grow into today’s richer multiple instead?

For a closer look at how this pricing stacks up against peers and the fair ratio, it is worth reviewing See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With Exponent presenting both appealing narratives and some areas of concern, it makes sense to review the numbers yourself and form a view quickly. To see how the balance of risk and potential reward stacks up, start with 5 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Exponent?

If Exponent has sharpened your focus on quality, now is the moment to widen your search and spot other opportunities before they move out of reach.

• Capture potential value by scanning 55 high quality undervalued stocks that combine solid fundamentals with share prices that sit below many investors’ radar.
• Strengthen your income focus by reviewing 9 dividend fortresses that put reliable cash returns at the centre of your watchlist.
• Protect against unwanted surprises by checking 81 resilient stocks with low risk scores that score well on resilience and financial stability.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.